2025-10-14 15:43 |
Detailed record - Similar records
|
2025-10-13 13:40 |
[DZNE-2025-01172]
Dissertation / PhD Thesis
Gockel, N. E.
Mechanisms of microglia-mediated synapse formation and elimination
112 pp. (2025)2025 = Dissertation, Rheinische Friedrich-Wilhelms-Universität Bonn, 2025
Early impairments at the synaptic level can lead to disruption of communication between neurons, triggering neurological diseases such as schizophrenia. Emerging evidence has identified microglia as a key player in shaping synaptic architecture, but the precise mechanisms remain insufficiently understood.This study aims to investigate mechanisms of microglia-mediated synapse formation and elimination in two physiological contexts: first, during postnatal development, targeting microglia-complement interactions and second, during adult homeostasis examining microglia-synapse crosstalk via neurotransmitter signaling.The first objective used two-photon in vivo imaging to assess changes in synaptic density, microglial surveillance dynamics and microglia-synapse contact rates in a mouse model of complement protein overexpression, recapitulating hallmark phenotypes of schizophrenia. [...]
Detailed record - Similar records
|
2025-10-13 10:02 |
[DZNE-2025-01171]
Journal Article
Špeh, A. ; Boada, M. ; Jessen, F. ; et al
Cardiovascular health and cognition in older adults: Variations across recruitment models and European countries in the MOPEAD project.
BackgroundThe Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project aimed to identify the most effective and cost-efficient recruitment model for detecting prodromal and mild Alzheimer's disease (AD) across five European countries.ObjectiveTo examine differences in cardiovascular risk factors and cognitive performance among countries and recruitment models using MOPEAD data.MethodsIndividuals aged 65-85 with a high risk for prodromal or mild AD were included. Four recruitment models were used: a web-based screening tool, an open house initiative (OHI), a primary care-based protocol for early detection of cognitive decline, and a tertiary care-based screening at a diabetologist clinic. [...]
Detailed record - Similar records
|
2025-10-13 09:59 |
Detailed record - Similar records
|
2025-10-13 09:58 |
Detailed record - Similar records
|
2025-10-13 09:52 |
Detailed record - Similar records
|
2025-10-13 09:49 |
Detailed record - Similar records
|
2025-10-13 09:46 |
Detailed record - Similar records
|
2025-10-10 15:23 |
Detailed record - Similar records
|
2025-10-10 15:19 |
Detailed record - Similar records
|
|
|